Japan, July 1 -- ASTELLAS PHARMA INC,TRON -TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ GEMEINNUETZIGE GMBH has got intellectual property rights for 'DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2.' Other related details are as follows:

Application Number: JP,2021-210851

Category (FI): C12N15/13,A61K39/395@T,C12N15/62@Z,C07K19/00,A61K45/00,A61K47/68,A61K39/395@L,A61P35/04,A61K31/537,A61K47/65,A61P35/00,A61K38/04,C07K16/46,C07K16/28,C07K16/30

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Dec. 24, 2021

Publication Date: Feb. 22, 2022

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syn...